A61P 33 - Antiparasitic agents

Patents for A61P 33 - Antiparasitic agents (21,787)
10/2011
10/19/2011	CN101570515B Curcumin substituted uracil derivative, preparation method and use thereof
10/19/2011	CN101040936B Compound Chinese traditional medicine agent for preventing fish verminosis
10/18/2011	US8038986 Immunogenic compositions and diagnostic and therapeutic uses thereof
10/18/2011	CA2478813C Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/13/2011	WO2011125469A1 Micro-rna-regulated recombinant vaccinia virus and utilization thereof
10/13/2011	US20110251247 Substituted isoxazoline derivatives
10/13/2011	US20110251210 Modified chloroquines with single ring moiety or fused ring moiety
10/13/2011	US20110251209 Compounds for treating parasitic disease
10/13/2011	US20110250265 Vaccine Preparation for Neospora Caninum Infection
10/13/2011	US20110250225 Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
10/13/2011	US20110250130 Tnf-alpha binding proteins
10/13/2011	CA2795695A1 Microrna-controlled recombinant vaccinia virus and use thereof
10/12/2011	EP2373610A1 Plant extracts from acronychia species and their use
10/12/2011	CN1981761B Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
10/12/2011	CN1980638B Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
10/12/2011	CN102210663A Diarylalkanes as potent inhibitors of binuclear enzymes
10/12/2011	CN101317914B Decoction medicament for treating scabies
10/12/2011	CN101199645B Heat-transfer dose medicament for treating ascariasis bellyache
10/11/2011	US8034379 Hydrophilic gel foaming matrix; cellulose ethers
10/11/2011	US8034351 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/11/2011	CA2553413C Insecticidal combination effective against fleas on mammals, particularly cats and dogs
10/11/2011	CA2513269C Repellent
10/11/2011	CA2488934C Aryl oxime derivatives as phosphodiesterase iv inhibitors for the treatment of diseases
10/11/2011	CA2382177C Method of treating body insect infestation
10/06/2011	WO2011123773A1 Parasiticidal compositions comprising multiple active agents, methods and uses thereof
10/06/2011	WO2011121096A1 PYRAZOL[1,5-a]PYRIMIDINE DERIVATIVES AS WNT PATHWAY ANTAGONISTS
10/06/2011	WO2011120359A1 Low hemolytic antimicrobial peptide, pharmaceutical composition and use thereof
10/06/2011	WO2011120182A2 Use of at least one dialkyl thiosulfonate or thiosulfinate for reducing the number of apicomplexa in an animal
10/06/2011	WO2010102363A8 Auxotrophic, recombinant bcg strain pasteur and use thereof for combating human infections caused by parasites
10/06/2011	WO2009100489A8 Crystal structure of pfa-mi and the pfa-mi co4 complex
10/06/2011	US20110245759 Methods of Treating An Infection with Nitric Oxide
10/06/2011	US20110245282 Compounds
10/06/2011	US20110245274 Isoxazolines derivatives and their use as pesticide
10/06/2011	US20110245239 Organic compounds
10/06/2011	US20110245227 Pyridone gpr119 g protein-coupled receptor agonists
10/06/2011	US20110245221 Aryl isoxazole compounds with antitumoural activities
10/06/2011	US20110245191 Parasiticidal compositions comprising multiple active agents, methods and uses thereof
10/06/2011	US20110243982 Chimeric MSP-Based Malaria Vaccine
10/06/2011	US20110243980 Methods and systems for o-glycosylating proteins
10/06/2011	US20110243979 Method of Transcutaneous Immunization Using Antigen
10/06/2011	US20110243950 Msp2 antigenic peptides and their use
10/06/2011	US20110243930 Compositions and methods for the treatment of immune related diseases
10/06/2011	CA2795290A1 Use of at least one dialkyl thiosulfonate or thiosulfinate for reducing the number of apicomplexa in an animal
10/06/2011	CA2793880A1 Parasiticidal compositions comprising multiple active agents, methods and uses thereof
10/05/2011	EP2370411A2 Compounds having antiparasitic or anti-infectious activity
10/05/2011	EP1812002B1 Treatment of mastitis
10/05/2011	CN102206277A Antibodies that bind human interleukin-18 and methods of making and using
10/05/2011	CN102206250A Low hematolysis antimicrobial peptide, pharmaceutical composition and use thereof
10/05/2011	CN101810627B Compound sulfamonomethoxine/compound sulfamonomethoxine sodium injection and preparation method
10/05/2011	CN101312727B Anti-worm formulation
10/05/2011	CN101270361B Japanese blood fluke TSP protein extracellular cyclo-2 encoding gene, polypeptide, amalgamation protein and uses in preparing vaccine
10/05/2011	CN101161284B Novel antimicrobial peptides with heparin binding activity
10/04/2011	US8030462 Immunotherapy; induce immunology response
10/04/2011	US8030067 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
10/04/2011	CA2669481C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels
09/2011
09/29/2011	WO2011117346A1 Endoparasiticidal compositions
09/29/2011	WO2011086531A3 New anti-malarial agents
09/29/2011	US20110237577 Bicyclic peptidomimetic inhibitors of aspartyl-proteases for the treatment of infectious diseases
09/29/2011	US20110237550 5-azaindole bisphosphonates
09/29/2011	US20110236468 Vaccine compositions
09/29/2011	US20110236439 Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
09/29/2011	US20110236419 Recombinant cdv compositions and uses thereof
09/29/2011	US20110236365 Method for protecting and treating at least one muscarinic receptor from dysfunction resulting from free radical damage
09/29/2011	US20110236325 Methods to treat or prevent a skin condition using a nell1 peptide
09/29/2011	CA2793884A1 Crystalline forms of a macrolide, and uses therefor
09/29/2011	CA2793578A1 Endoparasiticidal compositions
09/28/2011	EP2368575A2 Dry formulation for transcutaneous immunization
09/28/2011	EP2367551A1 S1p lyase inhibitors for the treatment of cerebral malaria
09/28/2011	EP1506005B1 Methods for the in vitro culture of sporozoea sp. and use thereof
09/28/2011	CN1630712B Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
09/28/2011	CN102203063A Carbazole compounds and therapeutic uses of the compounds
09/28/2011	CN102202671A Composition and use of a long-acting oral bioadhesive endoparasiticide gel based on doramectin
09/28/2011	CN102199147A Nitroimidazole derivative in therapy
09/28/2011	CN102199134A Thiadiazole histone deacetylase inhibitors and application thereof
09/28/2011	CN102198267A Recombinant bacillus calmette guerin vaccine for toxoplamasis and preparation method thereof
09/28/2011	CN102198122A Application of abietate in preparation of drug for killing schistosoma
09/28/2011	CN102198099A Toltrazuril suspension and preparation method thereof
09/28/2011	CN101953962B Chinese traditional medicine and granular preparation for treating cestodosis and preparation method thereof
09/28/2011	CN101669911B Dicazuril soluble powder and preparation method thereof
09/28/2011	CN101565418B Amide derivative and purpose thereof
09/27/2011	CA2370206C Pharmaceutical compositions for inhibition of cytokine production and secretion
09/22/2011	WO2011116348A1 Boron-containing small molecules as anti-protozoal agent
09/22/2011	US20110230533 Imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use
09/22/2011	US20110230451 Identification and use of compounds that affect the fidelity of eukaryotic translation initiation codon selection
09/22/2011	US20110230443 IMIDAZO[1,2-a] PYRIDINYL BISPHOSPHONATES
09/22/2011	US20110230429 Avermectin b1 and avermectin b1 monosaccharide derivatives having an alkoxymethyl substituent in the 4"-or 4'-position
09/22/2011	US20110229583 Human Medicinal Treatment Typically Using Salt of Peroxymonosulfuric Acid
09/22/2011	US20110229531 Anti-protozoa compounds
09/22/2011	US20110229517 System and process for producing multi-component biopharmaceuticals
09/22/2011	US20110229514 Vaccine and immunization method using plasmodium antigen 2
09/22/2011	US20110229476 Monospecific and multispecific antibodies and method of use
09/22/2011	US20110229423 Pacap signaling pathway modulators for treating inflammatory skin diseases having a neurogenic component, notably rosacea, and compositions comprised thereof
09/21/2011	EP2366684A1 New compounds of the pterocarpanquinone family, method for preparing the same, pharmaceutical composition containing the new compounds of the pterocarpanquinone family, uses and therapeutic method
09/21/2011	EP2366389A1 Severe sepsis preventive therapeutic agent
09/21/2011	CN1879628B An in-vitro trichomonas vaginalis treating vaginal suppository and preparation method thereof
09/21/2011	CN1468089B Microparticles for delivery of the heterologous nucleic acids
09/21/2011	CN102196820A S1P receptor agonists for the treatement of cerebral malaria
09/21/2011	CN102196808A S1P lyase inhibitors for the treatment of cerebral malaria
09/21/2011	CN102188705A Medicament composition containing bis cyclooctane derivatives
09/21/2011	CN102188703A Usage of yeast in preparation of anticoccidial drugs

1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 218